Literature DB >> 18206428

Intermittent hypoxia reduces cerebrovascular sensitivity to isocapnic hypoxia in humans.

Jordan S Querido1, Jesse B Godwin, A William Sheel.   

Abstract

The purpose of this study was to determine the changes in human cerebrovascular function associated with intermittent poikilocapnic hypoxia (IH). Healthy men (n=8; 24+/-1 years) were exposed to IH for 10 days (12% O(2) for 5min followed by 5min of normoxia for 1h). During the hypoxic exposures, oxyhemoglobin saturation (SaO(2)) was 85% and the end-tidal partial pressure of CO(2) was permitted to fall as a result of hypoxic hyperventilation. Pre- and post-IH intervention subjects underwent a progressive isocapnic hypoxic test where ventilation, blood pressure, heart rate, and cerebral blood flow velocity (middle cerebral artery, transcranial Doppler) were measured to determine the ventilatory, cardiovascular and cerebrovascular sensitivities to isocapnic hypoxia. When compared to the pre-IH trial, cerebrovascular sensitivity to hypoxia significantly decreased (pre-IH=0.28+/-0.15; post-IH=0.16+/-0.14cms(-1)%SaO(2)(-1); P<0.05). No changes in ventilatory, blood pressure or heart rate sensitivity were observed (P>0.05). We have previously shown that the ability to oxygenate cerebral tissue measured using spatially resolved near infrared spectroscopy is significantly reduced following IH in healthy humans. Our collective findings indicate that intermittent hypoxia can blunt cerebrovascular regulation. Thus, it appears that intermittent hypoxia has direct cerebrovascular effects that can occur in the absence of changes to the ventilatory and neurovascular control systems.

Entities:  

Mesh:

Year:  2007        PMID: 18206428     DOI: 10.1016/j.resp.2007.11.002

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  8 in total

1.  Regional hypoxic cerebral vasodilation facilitated by diameter changes primarily in anterior versus posterior circulation.

Authors:  J Mikhail Kellawan; John W Harrell; Alejandro Roldan-Alzate; Oliver Wieben; William G Schrage
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Effects of 10 days of modest intermittent hypoxia on circulating measures of inflammation in healthy humans.

Authors:  Jordan S Querido; Andrew William Sheel; Rupi Cheema; Stephan Van Eeden; Alan T Mulgrew; Najib T Ayas
Journal:  Sleep Breath       Date:  2011-07-09       Impact factor: 2.816

Review 3.  Integrative regulation of human brain blood flow.

Authors:  Christopher K Willie; Yu-Chieh Tzeng; Joseph A Fisher; Philip N Ainslie
Journal:  J Physiol       Date:  2014-01-06       Impact factor: 5.182

4.  Two-week normobaric intermittent-hypoxic exposures stabilize cerebral perfusion during hypocapnia and hypercapnia.

Authors:  Peizhen Zhang; Xiangrong Shi; H Fred Downey
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-11

5.  Effects of intermittent hypoxia on the cerebrovascular responses to submaximal exercise in humans.

Authors:  Jordan S Querido; James L Rupert; Donald C McKenzie; A William Sheel
Journal:  Eur J Appl Physiol       Date:  2008-11-08       Impact factor: 3.078

Review 6.  Hypoxemia, oxygen content, and the regulation of cerebral blood flow.

Authors:  Ryan L Hoiland; Anthony R Bain; Mathew G Rieger; Damian M Bailey; Philip N Ainslie
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-16       Impact factor: 3.619

7.  Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans.

Authors:  Glen E Foster; Julien V Brugniaux; Vincent Pialoux; Cailean T C Duggan; Patrick J Hanly; Sofia B Ahmed; Marc J Poulin
Journal:  J Physiol       Date:  2009-05-05       Impact factor: 5.182

8.  Changes in oxygen partial pressure of brain tissue in an animal model of obstructive apnea.

Authors:  Isaac Almendros; Josep M Montserrat; Marta Torres; Constancio González; Daniel Navajas; Ramon Farré
Journal:  Respir Res       Date:  2010-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.